FDA Withdraws Rule on Internal Research Misconduct Investigations

Washington Drug Letter
A A
The FDA is withdrawing a direct final rule that exempted it from disclosing certain scientific research misconduct records on FDA staff or someone working on behalf of the agency.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00